Active Recombinant Human LILRB4, His-tagged

• Cat.No.: LILRB4-318H
• Product Overview: Recombinant Human LILRB4 (Accession # AAH26309) Pro17-His257, fused with a C-terminal 6-His tag, was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: His
• Predicted N Terminal: Pro17& Ala (N+3 of signal derived sequence)
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its binding ability in a functional ELISA.When Recombinant Human LILRB4/CD85k/ILT3 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with an apparent Kd <1 nM.
• Molecular Mass: Recombinant Human LILRB4, His-tagged has a calculated MW of 27 kDa. In SDS-PAGE migrates as 29-43 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE with silver staining.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Protein length: 17-257 a.a.

Gene Information

• Gene Name: LILRB4 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 [ Homo sapiens ]
• Official Symbol: LILRB4
• Synonyms: HM18; ILT3; LIR5; CD85K; LIR-5; LILRB5
• Gene ID: 11006
• mRNA Refseq: NM_006847.3
• Protein Refseq: NP_006838.3
• MIM: 604821
• UniProt ID: Q8NHJ6
• Chromosome Location: 19q13.4